Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy
Virginia Haurigot(Spark Therapeutics (United States)), Fátima Bosch(Universitat Autònoma de Barcelona)
Cited by 231
Related Papers
Long-Term Retinal PEDF Overexpression Prevents Neovascularization in a Murine Adult Model of Retinopathy
|PLoS ONE|2012|75
Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC
|Disease Models & Mechanisms|2016|27